Literature DB >> 2670816

AIDS-dementia-complex: pathology, pathogenesis and future directions.

M C Dal Canto1.   

Abstract

Acquired immunodeficiency syndrome (AIDS), first described in 1981, is produced by infection with a retrovirus of the lentivirus family, now called human immunodeficiency virus (HIV). While, initially, the disease was almost exclusively seen in homosexual men, it has become apparent that numerous other categories of people are at risk, i.e., drug addicts who share dirty needles, hemophiliacs and haitians. In addition, epidemiological data from the industrialized nations clearly indicate that heterosexual contact is becoming an important source of viral transmission, as it has been known to occur in several african nations for many years. Initially, studies on patients with AIDS mainly focused on the immunosuppressive effects of the virus and on the various opportunistic infections and neoplastic complications that followed. Not much attention was given to a possible direct HIV infection of the nervous system. Consequently, patients who presented with neurological findings were simply considered to harbor in the CNS the same complications that occurred in other organs. While this was true in many cases, it has become also apparent that important changes in the central and peripheral nervous systems are due to direct viral involvement of these tissues. The first important step in the understanding of nervous system involvement in AIDS was the demonstration, in 1985, of HIV in the CSF and cerebral tissues of patients with neurological symptoms (47). Further studies have shown that, while opportunistic infections and neoplastic complications certainly contribute to the neurological morbidity of AIDS, the most important neuropathological changes, particularly in the brain, are due to direct HIV infection. The aim of this paper is to review the pathology of HIV-induced encephalitis and to discuss pathogenetic hypotheses regarding mechanisms of HIV-mediated tissue injury and the clinical manifestations that follow, particularly the syndrome now known as AIDS-Dementia-Complex (ADC). First, however, it may be appropriate to quickly review some basic notions on the biology of the virus.

Entities:  

Mesh:

Year:  1989        PMID: 2670816     DOI: 10.1007/bf02333773

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  82 in total

1.  Immunopathogenesis of human immunodeficiency virus infection in the central nervous system.

Authors:  H E Gendelman; J M Leonard; F Dutko; S Koenig; J Khillan; M S Meltzer
Journal:  Ann Neurol       Date:  1988       Impact factor: 10.422

2.  Pathologic features of AIDS encephalopathy in children: evidence for LAV/HTLV-III infection of brain.

Authors:  L R Sharer; L G Epstein; E S Cho; V V Joshi; M F Meyenhofer; L F Rankin; C K Petito
Journal:  Hum Pathol       Date:  1986-03       Impact factor: 3.466

3.  Blood-brain barrier protein recognized by monoclonal antibody.

Authors:  N H Sternberger; L A Sternberger
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

4.  Subacute encephalitis in acquired immune deficiency syndrome: a postmortem study.

Authors:  S L Nielsen; C K Petito; C D Urmacher; J B Posner
Journal:  Am J Clin Pathol       Date:  1984-12       Impact factor: 2.493

5.  Pneumocystis pneumonia--Los Angeles.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1981-06-05       Impact factor: 17.586

Review 6.  Neurologic manifestations of infection with human immunodeficiency virus. Clinical features and pathogenesis.

Authors:  D H Gabuzda; M S Hirsch
Journal:  Ann Intern Med       Date:  1987-09       Impact factor: 25.391

7.  Immunohistochemical localization of human and simian immunodeficiency viral antigens in fixed tissue sections.

Authors:  J M Ward; T J O'Leary; G B Baskin; R Benveniste; C A Harris; P L Nara; R H Rhodes
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

Review 8.  Treatment of patients with acquired immunodeficiency syndrome and associated manifestations.

Authors:  L D Kaplan; C B Wofsy; P A Volberding
Journal:  JAMA       Date:  1987-03-13       Impact factor: 56.272

9.  Association of different allelic forms of group specific component with susceptibility to and clinical manifestation of human immunodeficiency virus infection.

Authors:  L J Eales; K E Nye; J M Parkin; J N Weber; S M Forster; J R Harris; A J Pinching
Journal:  Lancet       Date:  1987-05-02       Impact factor: 79.321

10.  Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen.

Authors:  D H Smith; R A Byrn; S A Marsters; T Gregory; J E Groopman; D J Capon
Journal:  Science       Date:  1987-12-18       Impact factor: 47.728

View more
  1 in total

1.  AIDS-myelopathy. A neuropathological study.

Authors:  M Bergmann; F Gullotta; K Kuchelmeister; T Masini; G Angeli
Journal:  Pathol Res Pract       Date:  1993-02       Impact factor: 3.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.